Archives
-
Smarter Natural Product Screens for Cryptosporidium
2026-09-10
A mechanism-aware strategy for translating Cryptosporidium parvum AdhE biology into natural product screening, orthogonal validation, and more disciplined antiparasitic lead prioritization.
-
Alfuzosin HCl: From Receptor Biology to Translation
2026-09-10
A translational framework for using Alfuzosin HCl to connect α1-adrenergic receptor biology, lower urinary tract assays, formulation strategy, and clinically relevant decision-making in benign prostatic hyperplasia research.
-
Dihydroartemisinin: Assay Design Beyond Parasite Killing
2026-09-09
Dihydroartemisinin is examined here through an evidence-centered framework that separates parasite activity from host-cell signaling effects. The article combines compound-handling guidance, orthogonal assay design, and practical interpretation of antimalarial research data.
-
Tamsulosin for Postoperative Urinary Retention
2026-09-09
This systematic review and meta-analysis synthesized randomized evidence on perioperative Tamsulosin for preventing postoperative urinary retention. Across 22 quantitatively analyzed controlled studies, Tamsulosin reduced retention risk and increased maximum urinary flow rate, while showing no significant effect on surgery duration, urinary symptom scores, quality of life, or urinary tract infection incidence.
-
Sisomicin vs. Tobramycin in Clinical Isolates
2026-09-08
Stewart and Bodey evaluated sisomicin against 565 clinical isolates and compared its in vitro activity with gentamicin, Tobramycin, amikacin, butirosin, and kanamycin. The study showed broad activity against many Gram-negative bacilli, but also demonstrated that gentamicin- and tobramycin-resistant isolates were usually resistant to sisomicin, highlighting the importance of cross-resistance and amikacin susceptibility testing.
-
Galactose-Functionalized Micelles for Senolytic Delivery
2026-09-08
The reference study develops galactose-functionalized amphiphilic micelles that deliver Navitoclax preferentially to senescent cells through lysosomal β-galactosidase responsiveness. This formulation reduced toxicity toward non-senescent cells and improved the senolytic index, providing a practical platform for more selective senescence-targeted drug delivery.
-
2,2,2-Trichloroethanol: From Gel to Translation
2026-09-07
A translational perspective on 2,2,2-Trichloroethanol as a protein analysis reagent, showing how disciplined molecular biology research and orthogonal dopamine transporter imaging can improve confidence in cell-therapy studies without confusing assay support with therapeutic evidence.
-
Ciprofloxacin Hydrochloride Beyond Antibacterial Assays
2026-09-07
Ciprofloxacin hydrochloride offers translational researchers more than a familiar antibacterial benchmark. Its DNA replication mechanism, immunomodulatory observations, anthrax-treatment relevance, and role as a comparator in anti-Toxoplasma research create a framework for connecting assay design with therapeutic decision-making.
-
Müller Cell PEDF and Retinal Neuron Survival
2026-09-05
A 2026 study identifies a Müller cell pathway in which Ang-1 and Ang-2 oppositely regulate Tie-2–PI3K/Akt signaling, PEDF production, and retinal neuron survival. Its co-culture and gene-silencing experiments provide a mechanistic framework for studying neurovascular signaling under hypoxic stress.
-
DIDS Workflows for Chloride and Tumor Research
2026-09-04
DIDS combines anion transport inhibition with experimentally useful effects on chloride channels, TRPV1 signaling, vascular tone, and stress-surviving tumor cells. This guide translates those properties into controlled assay workflows, practical dose-finding strategies, and troubleshooting steps linked to metastasis research.
-
V5 Epitope Tag Peptide: Practical Protein Workflows
2026-09-04
Build more interpretable detection, competition, and immunoprecipitation controls around the V5 tag with a highly pure synthetic reference peptide. This workflow-oriented guide also shows how findings from single-molecule antibody screening can inform choices for dynamic imaging without confusing a peptide control with an antibody probe.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-09-03
Use dual-parameter Annexin V and 7-AAD staining to separate viable, early apoptotic, late apoptotic, and necrotic cells in rapid cytotoxicity and radiation-response studies. This workflow translates findings from BRD4-targeted FLASH radiosensitization research into practical assay design without overstating what a membrane-based endpoint can prove.
-
ABT-263: Mapping Mitochondrial Apoptosis
2026-09-03
ABT-263 (Navitoclax) is a high-affinity Bcl-2 family inhibitor for interrogating mitochondrial apoptosis, cancer biology, and senescence-related cell fate. This article explains how to use it as a mechanistic perturbation tool while distinguishing senolytic apoptosis from senomorphic remodeling.
-
Panobinostat (LBH589): Assay Design at the Stress Edge
2026-09-02
Panobinostat (LBH589) is a broad-spectrum HDAC inhibitor whose value extends beyond simple cytotoxicity measurements. This article presents a stress-threshold framework for interpreting epigenetic, apoptotic, resistance, and combination-response assays in cancer research.
-
Nitrocefin Workflows for β-Lactamase Research
2026-09-02
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal, supporting both visual screening and quantitative kinetic assays. This guide shows how to use the substrate to connect resistance profiling with practical β-lactamase inhibitor and peptide-validation workflows.